This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
2025 bracket Welcome to STAT Madness, a bracket-style contest to find the best innovation in science and medicine. Explore groundbreaking innovations from top institutions and help crown the 2025 STAT Madness champion. Your vote determines who advances in this competition celebrating the best in biomedical research.
A woman sat in our emergency department in agonizing pain, feeling shaky, nauseous, and weak — drug withdrawal was setting in. But she wasn’t a “junkie” or even a recreational drug user. She was in her mid-60s with advanced cancer in her ovaries that had spread to her abdomen, causing unbearable pain.
Welcome to the 2025 edition of STAT Madness, our bracket-style competition in which you, the readers, choose the most impressive biomedical and health research published last year. Voting begins today. research institutions and companies.
Over the last week, companies developing artificial intelligence products for health care have announced a series of impressive fundraises that set the tone for what could be a banner year for AI investment. Timed to the J.P.
businesses in 2025. 📆 March 4, 2025 at 11:00 am PT, 2:00 pm ET, 7:00 pm GMT Key Takeaways: Insights into the latest payroll compliance trends affecting U.S. Strategies for managing multi-state compliance requirements with confidence. How automation and technology streamline payroll and mitigate compliance risks.
I’ve compiled this YouTube video to help candidates best prepare for their 2025 BCPS pharmacy exam. There are significant changes this year in the 2025 BCPS Exam compared to last spring. Here […] The post 2025 BCPS Pharmacy Exam – What You Need To Know appeared first on Med Ed 101.
Changes to allow hub and spoke dispensing between different legal entities are likely to come in late 2025, Community Pharmacy England (CPE) has said. Hub and spoke […] The post Hub and spoke changes 'likely in late 2025' but supervision legislation 'not imminent' appeared first on The Pharmacist.
The 3rd edition of Pharma Live Expo & Summit will be held from April 17 to 19, 2025, at the Bombay Exhibition Centre, Mumbai. Pharma Live Expo & Summit 2025 provides a unique platform for stakeholders across the pharmaceutical value chain to come together, exchange knowledge, and drive impactful advancements.
The eligible patient cohorts for vaccination under the spring 2025 Covid-19 programme have been confirmed, following recommendations from government advisors.
I’ve put together an approximately 20-minute video on the BCMTMS exam and what you can expect for 2025. General information on the 2025 BCMTMS Exam Who writes the exam? About The BCMTMS Exam Content Domains […] The post 2025 BCMTMS Exam – How To Prepare? appeared first on Med Ed 101.
Looking ahead to 2025, were witnessing an industry in transformation. Looking ahead: What 2025 holds Supply chain management has come a long way from its humble beginnings. As we look to 2025, the focus must be on building supply chains that are not just efficient but also resilient, sustainable, and deeply aligned with patient needs.
Community Pharmacy Contractual Framework negotiations have now begun for the 2024/25 and 2025/26 funding agreements, the government has announced. Minister of state for care Stephen Kinnock […] The post BREAKING: Pharmacy contract negotiations begin for 2024/25 and 2025/26 appeared first on The Pharmacist.
billion in 2025, a spokesperson for the Centers for Medicare and Medicaid Services confirmed to STAT. Medicare’s actuaries expect the drug Leqembi , made by the Japanese drugmaker Eisai and sold in partnership with Biogen, to cost the traditional Medicare program around $550 million in 2024, and the entire Medicare program $3.5
The result: In 2025, right after a new president is elected, Medicare Advantage insurers will have to absorb a slight decrease of 0.2% to the baseline payment rates that insurers receive from the government for enrolling older adults and people with disabilities.
That’s why the federal government expects enrollment in the $500 billion Medicare Advantage program to grow once again in 2025 — a stark contrast from insurers’ cries that modest payment reforms would damage them and seniors’ options.
billion in January 2025, according to data from GlobalData. These three transactions accounted for 64 per cent of the total M&A deal value in January 2025. per cent in January 2025 compared to the same period last year. billion in Jan 2025 appeared first on Express Pharma. A total of 129 VC deals worth $4.5
Accretion Pharmaceuticals, an Ahmedabad-headquartered pharmaceuticals manufacturer, announced that its initial public offering (IPO) will open for subscription on Wednesday, May 14, 2025. The anchor portion will be opened on Tuesday, May 13, 2025, and the issue will conclude on Friday, May 16, 2025.
The company indicated that the investigation began in 2017 and picked up in intensity in late 2024 and early 2025. The SEC filing states that on Feb. Continue to STAT+ to read the full story…
billion in Q1 2025, according to the Grant Thornton Bharat Pharma & Healthcare Dealtracker. When adjusted for that outlier, Q1 2025 shows a 15 per cent increase in deal value. M&A activity in Q1 2025 comprised 25 deals worth USD 1.5 Indias pharma and healthcare sector recorded 71 deals amounting to USD 2.6
Community Pharmacy England has agreed a 3.073 billion Community Pharmacy Contractual Framework, in a new deal for the sector for 2025/26. The medicines margin for 2025/26 […] The post BREAKING: Community pharmacies get 3bn deal for 2025/26 appeared first on The Pharmacist.
Building upon the foundation laid by previous initiatives, the Union Budget 2025 could prioritise targeted incentives for AI in research and development, which will accelerate innovation in drug discovery, clinical trials, and personalised patient care.
The Union Budget 2025-26 represents an opportunity for India to recalibrate policies that will drive the pharmaceutical sector forward as it approaches significant economic and industrial growth. In Conclusion, the Union Budget 2025-26 presents a key opportunity to boost Indias pharmaceutical sector.
The committee recommended that the 2025-2030 Dietary Guidelines “include more nutrient-dense plant-based meal and dietary recommendation options,” prioritize plant-based protein over animal protein, and center plain water, instead of dairy milk and soda, as a beverage of choice.
To achieve this, the Union Budget 2025-2026 should prioritise innovation, ease of doing business, and policies that strengthen the Life Sciences Ecosystem. ” The post Association leaders share their expectations from Budget 2025-26 appeared first on Express Pharma. This will position India among the top 5 innovators and No.
4, 2025 , implies that the oncologists in NCI’s Investigational Drug Branch (IDB) colluded with the drug company Exilixis to sponsor two Phase 3 studies of its drug cabozantanib. Mark Ratain’s First Opinion piece of Feb. Ratain concludes by recommending that IDB be abolished.
The post Pharma sector gears up for Budget 2025-26; urges for strong regulatory framework and faster approval pathways appeared first on Express Pharma.
For 2025, the three largest pharmacy benefit managers (PBMs)Caremark (CVS Health), Express Scripts (Cigna), and Optum Rx (United Health Group)have again each excluded hundreds of drugs from their standard formularies. In fact, nearly all marketed Humira biosimilars are excluded from the larger PBMs 2025 formularies. What do you think?
The post Nutraceuticals 2025: Mapping growth, innovation, and consumer-centric trends appeared first on Express Pharma. Todays consumers are more aware and proactive about their health and fitness levels and are seeking products that are not only effective but also to a large extent, tailored to their unique needs.
The DOJ began looking into the company in 2017, according to Semler, but re-upped its investigation in late 2024 and early 2025. The deal would cap an investigation Semler first disclosed in February into whether federal health programs paid out improper claims based on the use of QuantaFlo, which would violate the False Claims Act.
million in February 2025 from $ 300 million in January 2025. The decline in investment activity makes February 2025 one of the lowest-funded months in the past 12 months in the sector. MOC and Apex Kidney Care reported some of the biggest funding rounds in February 2025, raising $18 million and $9 million respectively.
Drawing from DCIs new 2025 Economic Report on U.S. Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Last week, we examined the growing concentration of specialty drug dispensing revenues among the largest pharmacies. Today, we dive deeper. All rights reserved.
In 2025, the strategies that succeed are rooted in personalization, innovation, and real-time adaptability. In 2025, the ability to react to these preferences in near real time is what separates leading pharma marketing teams from the rest. FAQs What is the biggest trend in marketing in pharma in 2025?
Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk’s diabetes drug, liraglutide, to its platform in 2025. ” The post Hims & Hers Health to introduce generic Liraglutide in 2025 amid growing demand for weight-loss medications appeared first on Express Pharma.
Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. While some major companies have narrowed their focus or unwound previous integration efforts, ongoing consolidation and selective deconsolidation will continue to reshape the healthcare biome by trying to build something epic, block by block.
At least that was the hope of many in the sector who started 2025 pointing to scientific advances and falling interest rates. This was supposed to be the year of biotech’s comeback. Some foresaw a pickup in buyouts and initial public offerings, rewarding investors in the highly risky and cyclical business of bringing drugs to market.
The Healthcare Businesswomens Association (HBA) has proudly announced its 2025 class of Rising Star and Luminary honorees! Congratulations to the following honorees: 2025 HBA Rising Stars Jenn Wong Abbott Xongi Phaleng AbbVie Inc. We look forward to seeing you there! Vandana Rajakumar AbbVie Inc.
per cent to $79 million in March 2025, up from $43.5 million in February 2025. Truemeds and DCDC secured two of the largest funding rounds in March 2025, raising $44 million and $17.4 The post Pharma funding rises 81 per cent in march 2025, late-stage deals lead appeared first on Express Pharma. million, or 77.8
Swedish biotech company Neogap Therapeutics has been chosen to join Innovate Nordics 2025 acceleration programme, a prestigious initiative designed to help Nordic growth companies expand into the US market.
The findings, disclosed in a press release, suggest the company may be on track to bring a combination flu and Covid vaccine to the market, potentially as early as autumn 2025.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content